Oral rotavirus vaccines: How well will they work where they are needed most?

Journal of Infectious Diseases

Volumn 200, Issue SUPPL. 1, 2009, Pages

  Patel, Manish ^a   Shane, Andi L ^b   Parashar, Umesh D ^a   Jiang, Baoming ^a   Gentsch, Jon R ^a   Glass, Roger I ^a,c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; MATERNAL ANTIBODY; ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE;

CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENCY; DRUG WITHDRAWAL; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LOWEST INCOME GROUP; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SOCIAL STATUS; SYSTEMATIC REVIEW; VIRUS INFECTION; VIRUS STRAIN;

ADMINISTRATION, ORAL; ANTIBODIES, VIRAL; BREAST FEEDING; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; INTESTINES; MALNUTRITION; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 72849111380     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605035     Document Type: Review

References (73)

1. World Health Organization. Global and national estimates of deaths under age five attributable to rotavirus infection: 2004. Available at: http://www.who.int/immunization-monitoring/burden/rotavirus-estimates/en/. Accessed 16 June 2008.
2. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947) (Pubitemid 43048947)
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948) (Pubitemid 43048948)
5. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-295
6. World Health Organization, Childrens Vaccine Initiative. Rotavirus vaccines for immunization of children in developing countries. In: World Health Organization meeting report: consensus workshop. Geneva: World Health Organization, 1997.
7. GlaxoSmithKline. Clinical study register. Available at: http://www.gsk-clinicalstudyregister.com/index.jsp. Accessed 24 December 2008.
8. 8. De Mol P, Zissis G, Butzler JP, Mutwewingabo A, Andre FE. Failure of live, attenuated oral rotavirus vaccine. Lancet 1986; 2:108. (Pubitemid 16097112)
9. Georges-Courbot MC, Monges J, Siopathis MR, et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 1991; 142:405-411
10. Hanlon P, Hanlon L, Marsh V, et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1987; 1: 1342-1345 (Pubitemid 17076248)
11. Lanata CF, Black RE, del Aguila R, et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 1989; 159:452-459
12. Santosham M, Letson GW, Wolff M, et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 1991; 163:483-487
13. Perez-Schael I, Garcia D, Gonzalez M, et al. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 1990; 30:219-229 (Pubitemid 20146247)
14. Bernstein DI, Smith VE, Sander DS, Pax KA, Schiff GM, Ward RL. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 1990; 162:1055-1062
15. Christy C, Madore HP, Pichichero ME, et al. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J 1988; 7:645-650 (Pubitemid 18225098)
16. Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988; 158:570-587 (Pubitemid 18233661)
17. Rennels MB, Losonsky GA, Levine MM, Kapikian AZ. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strainMMU18006 in young children. Pediatr Infect Dis 1986; 5:587-588 (Pubitemid 16017569)
18. Vesikari T, Isolauri E, Delem A, et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 1985; 107:189-194 (Pubitemid 15241906) (Pubitemid 15241906)
19. Vesikari T, Isolauri E, DHondt E, Delem A, Andre FE, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984; 1:977-981 (Pubitemid 14148890)
20. Vesikari T, Ruuska T, Delem A, Andre FE, Beards GM, Flewett TH. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 1991; 80:173-180
21. Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI. Update on rotavirus vaccines. Pediatr Infect Dis J 2005; 24:947-952
22. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997; 337:1181-1187 (Pubitemid 27454449) (Pubitemid 27454449)
23. Lanata CF, Midthun K, Black RE, et al. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 1996; 174: 268-275 (Pubitemid 26251410)
24. Linhares AC, Gabbay YB, Mascarenhas JD, et al. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ 1996; 74:491-500. (Pubitemid 27015917)
25. Linhares AC, Lanata CF, Hausdorff WP, Gabbay YB, Black RE. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesushuman reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea. Pediatr Infect Dis J 1999; 18:1001-1006
26. Santosham M, Moulton LH, Reid R, et al. Efficacy and safety of highdose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 1997; 131:632-638 (Pubitemid 28006943) (Pubitemid 28006943)
27. United Nations Childrens Fund. State of the worlds children. 2008. Available at: http://www.unicef.org/sowc08/statistics/statistics.php. Accessed 24 December 2008.
28. Meeting of the Immunization Strategic Advisory Group of Experts, April 2009 - conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:220-236
29. Cunliffe NA, Kirsten M, Madhi S, et al. Efficacy of human rotavirus vaccine RIx4414 in Africa during the first year of life [abstract 572]. In: Program and abstracts of the 26th Meeting of the European Society of Pediatric Infectious Diseases, June 9-13, 2009 (Brussels, Belgium). 2009.
30. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-1189
31. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-2251
32. John TJ. Problems with oral poliovaccine in India. Indian Pediatr 1972; 9:252-256
33. Grassly NC, Fraser C, Enger J, et al New strategies for the elimination of polio from India. Science 2006; 314:1150-1153 (Pubitemid 44789046) (Pubitemid 44789046)
34. Grassly NC, Jafari H, Bahl S, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 2009 (Epub ahead of print).
35. Levine MM, Kaper JB, Herrington D, et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 1988; 2:467-470 (Pubitemid 18199823)
36. Kang G, Kelkar SD, Chitambar SD, Ray P, Naik T. Epidemiological profile of rotaviral infection in India: challenges for the 21st century. J Infect Dis 2005; 192(Suppl 1):S120-6.
37. Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. J Infect Dis 2005; 192(Suppl 1):S160-6.
38. Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002; 34:1351-1361 (Pubitemid 34507945) (Pubitemid 34507945)
39. De Vos B, Debrus S, Vesikari T, Ruiz Palacios GM, Steele AD, Ward R. The interference of transplacental antibodies on immune response to RIX 4414, a live attenuated human rotavirus (RV) vaccine. In: Proceedings of the International Meeting on Frontiers in Neonatal and Infant Immunity Conference (Madrid, Spain). 2005.
40. De Vos B, Vesikari T, Linhares AC, et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 2004; 23(Suppl 1):S179-82. (Pubitemid 44146429)
41. Glass RI. Where are we now and where are we going? In: Program and abstracts of the 8th International Rotavirus Syposium (Istanbul, Turkey). 2008.
42. Steele AD, Tumbo J, Armah G, De Vos B. Comparison of two different regimens (two doses versus three doses) in terms of reactogenicity and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 in South African infants. In: Program and abstracts of the 9th International Symposium on Double-Stranded RNA Viruses (Cape Town, South Africa). 2006.
43. Ward R. Immunity against rotavirus disease. In: Program and abstracts of the 7th International Rotavirus Workshop (Lisbon, Portugal). 2006: 7.
44. Lawrence RM, Pane CA. Human breast milk: current concepts of immunology and infectious diseases. Curr Probl Pediatr Adolesc Health Care 2007; 37:7-36.
45. Kerdpanich A, Chokephaibulkit K, Watanaveerade V, Vanprapar N. Feeding does not influence the immunogenicity of RIX4414 (Rotarix) in Thailand [poster 286]. In: Program ans abstracts of the 5th World Congress of the World Society for Pediatric Infectious Diseases (Bangkok, Thailand). 2007.
46. Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Role of humanmilk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998; 351:1160-1164 (Pubitemid 28171818) (Pubitemid 28171818)
47. Kent JC, Mitoulas LR, Cregan MD, Ramsay DT, Doherty DA, Hartmann PE. Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics 2006; 117:e387-95.
48. Glass RI, Stoll BJ. The protective effect of human milk against diarrhea: a review of studies from Bangladesh. Acta Paediatr Scand Suppl 1989; 351:131-136
49. Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 1996; 174(Suppl 1):S107-11.
50. Glass RI, Ing DJ, Stoll BJ, Ing RT. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children. Adv Exp Med Biol 1991; 310:249-254
51. Dennehy PH, Brady RC, Halperin SA, et al. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005; 24:481-488
52. Ing DJ, Glass RI, Woods PA, et al. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. Am J Dis Child 1991; 145:892-897
53. United Nations Childrens Fund. Integration of vitamin A supplementation with immunization: policy and programme implications. Geneva: Vaccines and Biologicals, World Health Organization, 1998.
54. Sazawal S, Black RE, Menon VP, et al. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics 2001; 108:1280-1286 (Pubitemid 33121469) (Pubitemid 33121469)
55. Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: ameta-analysis. Pediatrics 2007; 119:1120-1130 (Pubitemid 46871267) (Pubitemid 46871267)
56. Bresee JS, El Arifeen S, Azim T, et al. Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh. Pediatr Infect Dis J 2001; 20:1136-1143 (Pubitemid 34016426) (Pubitemid 34016426)
57. Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine 2008 (Epub ahead of print).
58. Myaux JA, Unicomb L, Besser RE, et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatr Infect Dis J 1996; 15:204-209 (Pubitemid 26098469) (Pubitemid 26098469)
59. Posey DL, Linkins RW, Oliveria MJ, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997; 175(Suppl 1):S258-63. (Pubitemid 27053519)
60. Lagos R, San Martin O,Wasserman SS, et al. Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103- HgR in Chilean infants and toddlers. Pediatr Infect Dis J 1999; 18: 624-630 (Pubitemid 29350330) (Pubitemid 29350330)
61. Cunliffe NA, Kilgore PE, Bresee JS, et al. Epidemiology of rotavirusdiarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ 1998; 76:525-537
62. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13:310-312
63. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349:1191-1197 (Pubitemid 27190041)
64. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192(Suppl 1): S146-59.
65. Gurgel RQ, Cuevas LE, Vieira SC, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2007; 13: 1571-1573
66. Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD. Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2008; 14:863-865
67. Madhi S, Lerumo T, Louw C, et al. Efficacy of human rotavirus vaccine RIX4414(Rotarix) in South African infants during the first year of life - an interim report [abstract P-39]. In: Program and abstracts of the 8th International Rotavirus Syposium (Istanbul, Turkey). 2008:61.
68. Van Den Driessche M, Peeters K, Marien P, Ghoos Y, Devlieger H, Veereman-Wauters G. Gastric emptying in formula-fed and breast-fed infants measured with the 13C-octanoic acid breath test. J Pediatr Gastroenterol Nutr 1999; 29:46-51. (Pubitemid 30345827) (Pubitemid 30345827)
69. Cavell B. Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand 1981; 70:639-641 (Pubitemid 12196516)
70. Choi AH, Basu M, McNeal MM, Bean JA, Clements JD, Ward RL. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr Purif 2004; 38:205-216 (Pubitemid 39527259) (Pubitemid 39527259)
71. Ciarlet M, Crawford SE, Barone C, et al. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol 1998; 72:9233-9246 (Pubitemid 28471870)
72. Jiang B, Estes MK, Barone C, et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 1999; 17:1005-1013 (Pubitemid 29074757) (Pubitemid 29074757)
73. Jiang B, Wang Y, Saluzzo JF, Bargeron K, Frachette MJ, Glass RI. Immunogenicity of a thermally inactivated rotavirus vaccine in mice.Hum Vaccin 2008; 4:143-147